Related Experiment Videos
[Hepatitis due to pirprofen; 3 cases, 1 fatality]
Annales De Gastroenterologie Et D'Hepatologie
|January 1, 1986
Summary
Pirprofen, a nonsteroidal anti-inflammatory drug, can cause jaundice and skin issues in women. Regular liver enzyme monitoring is advised due to potential severe reactions.
Area of Science:
- Pharmacology
- Hepatology
- Dermatology
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are widely used for pain and inflammation.
- Pirprofen is an NSAID with a known side effect profile.
- Drug-induced liver injury (DILI) is a significant concern in pharmacovigilance.
Observation:
- Three cases of jaundice were observed in women using pirprofen at 800 mg/day.
- Treatment durations ranged from 6 weeks to 4.5 months.
- Two patients also experienced cutaneous side effects, with one responding to corticosteroid treatment.
Findings:
- Pirprofen use is associated with hepatotoxicity, presenting as jaundice.
- Cutaneous adverse reactions can co-occur with liver injury.
- Prompt medical intervention may be necessary for managing side effects.
Implications:
- Hepatotoxicity from pirprofen necessitates careful patient selection and monitoring.
- Transaminase surveillance is crucial for early detection of liver injury.
- This highlights the importance of pharmacovigilance for NSAIDs.